Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease, Study. Circulation, vol.129, issue.8, pp.837-884, 2010. ,
Épidémiologie, étiologie et mécanisme de la fibrillation atriale ,
, Académie Nationale de Médecine, 2011.
Projections on the number of individuals with atrial fibrillation in the European Union, Eur Heart J, vol.34, issue.35, pp.2746-51, 2000. ,
Atrial fibrillation as an independant risk factor for stroke : The Framingham study, Stroke, vol.22, issue.8, pp.983-991, 1991. ,
Thromboembolism in atrial fibrillation, Am J Med, vol.105, issue.4, pp.502-512, 2010. ,
Thromboembolism associated with atrial fibrillation as a cause of limb and organ ischemia, Adv Clin Exp Med, vol.22, issue.6, pp.865-73, 2013. ,
, Haute Autorité de Santé. Les anticoagulants oraux, 2018.
ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS, Eur Heart J, vol.37, pp.2893-962, 2016. ,
Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach, CHEST, vol.137, issue.2, pp.263-72, 2010. ,
A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation. The Euro Heart Survey, vol.138, pp.1093-100, 2010. ,
Antithrombotic therapy for atrial fibrillation, Chest, vol.141, issue.2, pp.531-575, 2012. ,
Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis, Ann Intern Med, vol.131, issue.7, pp.492-501, 1999. ,
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial, Lancet, vol.370, issue.9586, pp.493-503, 2007. ,
Apixaban versus Warfarin in patients with atrial fibrillation, N Engl J Med, vol.365, issue.11, pp.981-92, 2011. ,
Dabigatran versus Warfarin in patients with atrial fibrillation, N Engl J Med, vol.361, issue.12, pp.1139-51, 2009. ,
Rivaroxaban versus Warfarin in nonvalvular atrial fibrillation, N Engl J Med, vol.365, issue.10, pp.883-91, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-01038111
Edoxaban versus Warfarin in patients with atrial fibrillation, N Engl J Med, vol.369, issue.22, pp.2093-104, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00934699
Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study, Circulation, vol.138, issue.1, pp.37-47, 2018. ,
Dabigatran use in elderly patients with atrial fibrillation, Thromb Haemost, vol.115, issue.1, pp.152-60, 2016. ,
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials, Lancet, vol.383, issue.9921, pp.955-62, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-00935589
Efficacy and harms of direct oral anticoagulants in the elderly for stroke prevention in atrial fibrillation and secondary prevention of venous thromboembolism, Circulation, vol.132, issue.3, pp.194-204, 2015. ,
Meta-Analysis of Direct-Acting Oral Anticoagulants Compared With Warfarin in Patients >75 Years of Age, Am J Cardiol, 2019. ,
Évaluation de la qualité de vie des patients âgés en fibrillation atriale sous anticoagulants au long cours : antivitamine K versus anticoagulants oraux directs. La Revue de Médecine Interne, vol.36, pp.175-181, 2015. ,
National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the diagnosis and management of atrial fibrillation, Heart Lung Circ, vol.27, pp.1209-66, 2018. ,
Korean Guideline of Atrial Fibrillation Management, 2018. ,
, Korean Circ J, 2018.
Antithrombotic therapy for Atrial Fibrillation, Chest, vol.154, pp.1121-201, 2018. ,
consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation, Journal of Arrhythmia, vol.33, issue.4, pp.345-67, 2017. ,
focused update of the Canadian Cardiovascular Society guidelines for the management of atrial fibrillation, Can J Cardiol, vol.34, pp.1371-92, 2018. ,
Underuse of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review, Am J Med, vol.123, issue.7, pp.638-683, 2010. ,
Underuse of Oral Anticoagulation for Individuals with Atrial Fibrillation in a Nursing Home Setting in France: Comparisons of Resident Characteristics and Physician Attitude, J Am Geriatr Soc, vol.63, issue.1, pp.71-77, 2015. ,
Clinical Characteristics and Outcomes in Extreme Elderly (Age ? 85 Years) Japanese Patients With Atrial Fibrillation: The Fushimi AF Registry, Chest, vol.149, issue.2, pp.401-413, 2016. ,
Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting, Arch Intern Med, vol.161, issue.20, pp.2458-63, 2001. ,
Polypharmacycutoff and outcomes: five or more medicineswereused to identifycommunity-dwellingolder men at risk of different adverse outcomes, J Clin Epidemiol, vol.65, issue.9, pp.989-95, 2012. ,
, ANSM. Interactions médicamenteuses et cytochromes, 2017.
Oral Anticoagulant Therapy Prescription in Patients With Atrial Fibrillation Across the Spectrum of Stroke Risk, JAMA, vol.1, issue.1, pp.55-62, 2016. ,
Oral anticoagulation therapy use in patients with atrial fibrillation after the introduction of non-vitamin K antagonist oral anticoagulants: findings from the French healthcare databases, BMJ Open [Internet], vol.9, issue.4, 2011. ,
Prévalence du traitement anticoagulant dans la prévention embolique de la fibrillation auriculaire chez le patient gériatrique hospitalisé, 2017. ,
Evaluation du traitement antithrombotique du sujet de plus de 75 ans aux antécédents de fibrillation auriculaire admis aux urgences du CHRU de Lille ,
La prescription des anticoagulants en unité de soins longue durée et en soins de suite et de réadaptation du CHU de Bordeaux : Les principaux facteurs associés à l'underuse, 2018. ,
Les anticogaulants en France en 2014: état des lieux, synthèse et surveillance, 2014. ,
Prescription des anticoagulants en médecine générale, 2014. ,
focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association, Eur Heart J, vol.33, issue.21, pp.2719-2766, 2012. ,
Misperceptions of aspirin efficacy and safety may perpetuate anticoagulant underutilization in atrial fibrillation, Eur Heart J, vol.36, issue.11, pp.653-659, 2015. ,
Underuse of Anticoagulation in Older Patients with Atrial Fibrillation and CHADS2 Score ? 2: Are We Doing Better Since the Marketing of Direct Oral Anticoagulants? Drugs&Aging, vol.34, pp.841-50, 2017. ,
Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation, J Am Coll Cardiol, vol.46, issue.9, pp.1729-1765, 2005. ,
Use of oral anticoagulant therapy in older adults with atrial fibrillation after acute ischemic stroke, J Am Geriatr Soc, vol.65, issue.2, 2016. ,
Attitudes of physicians regarding anticoagulation for atrial fibrillation: a systematic review, Age and Ageing, vol.40, issue.6, pp.675-83, 2011. ,
Use of oral anticoagulants in atrial fibrillation is highly variable and only weakly associated with estimated stroke risk: Cross-sectional population database study, Eur J Gen Pract, vol.20, pp.181-190, 2014. ,
Antithrombotic treatment in elderly patients with atrial fibrillation: a practical approach, BMC Cardiovasc Disord, vol.15, issue.143, 2015. ,
Dementia correlates with anticoagulation underuse in older patients with atrial fibrillation, Arch Gerontol Geriatr, vol.72, pp.108-120, 2017. ,
Risk of falls and major bleeds in patients on oral anticoagulation therapy, Am J Med, vol.125, issue.8, pp.773-781, 2012. ,
Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls, Arch Intern Med, vol.159, issue.7, pp.677-85, 1999. ,
Incidence of intracranial hemorrhage in patients with atrial fibrillation who are prone to fall, Am J Med, vol.118, issue.6, pp.612-619, 2005. ,
Mortality after ground-level fall in the elderly patient taking oral anticoagulation for atrial fibrillation/flutter: a long-term analysis of risk versus benefit, J Trauma Acute Care Surg, vol.76, issue.3, pp.642-651, 2014. ,
Thromboembolic and bleeding complications during oral anticoagulation therapy in cancer patients with atrial fibrillation: a Danish nationwide population-based cohort study, Cancer Med, vol.6, issue.6, pp.1165-72, 2017. ,
Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation, Blood adv, vol.2, pp.200-209, 2018. ,
Relation of Body Mass Index With Adverse Outcomes Among Patients With Atrial Fibrillation: A Meta-Analysis and Systematic Review, J Am Heart Assoc, vol.5, issue.9, p.4006, 2016. ,
Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis, Eur Heart J, vol.36, issue.46, pp.3238-3287, 2015. ,
La polymédication: définitions, mesures et enjeux. Revue de la littérature et tests de mesure. IRDES, 2014. ,
Adverse Drug Reactions, and Geriatric Syndromes, Clin Geriatr Med, vol.28, issue.2, pp.173-86, 2012. ,
Evaluation du risque hémorragique lié aux anticoagulants oraux: enquête de pratiques auprès des médecins généralistes concernant leurs patients atteints de fibrillation auriculaire, 2017. ,
Barriers to the use of anticoagulation for nonvalvular atrial fibrillation: a representative survey of Australian family physicians, Stroke, vol.39, issue.1, pp.227-257, 2007. ,
Anticoagulant-related bleeding in older persons with atrial fibrillation: physicians' fears often unfounded, Arch Intern Med, vol.163, issue.13, pp.1580-1586, 2003. ,
A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, clusterrandomised trial, Lancet, vol.390, pp.1737-1783, 2017. ,
Histoire de l'électrocardiogramme. Limoges, 2016. ,
Arythmies auriculaires : mécanisme, présentation ECG et traitement curatif. Revue Médicale Suisse, vol.2, 2006. ,
Comment définir la fibrillation atriale valvulaire? Arch Cardiovasc Dis, 2015. ,
A meta-analysis of the prognostic significance of atrial fibrillation in chronic heart failure, Eur J Heart Fail, vol.11, issue.7, pp.676-83, 2009. ,
ESC/ESH Guidelines for the management of arterial hypertension, Eur Heart J, vol.00, pp.1-98, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02042368
Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease, International Journal of Cardiology, vol.105, issue.3, pp.315-323, 2005. ,
The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study, BMJ, 2012. ,
Venous Thromboembolism Increases the Risk of Atrial Fibrillation: The Tromsø Study, J Am Heart Assoc, vol.3, issue.1, p.483, 2014. ,
Alcohol Consumption and Risk of Atrial Fibrillation: A Prospective Study and Dose-Response Meta-Analysis, JACC, vol.64, issue.3, pp.281-290, 2014. ,
Drug-induced atrial fibrillation, Journal of the American College of Cardiology, vol.44, issue.11, pp.2117-2141, 2004. ,
Global burden of atrial fibrillation in developed and developing nations, Global heart, vol.9, issue.1, pp.113-122, 2014. ,
Secular trends in incidence of atrial fibrillation in Olmsted County, Circulation, issue.114, pp.119-144, 1980. ,
Projections on the number of individuals with atrial fibrillation in the European Union, Eur Heart J, vol.34, issue.35, pp.2746-51, 2000. ,
Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis, Nat Rev Cardiol, vol.13, issue.6, pp.321-353, 2016. ,
Racial differences in the incidence of and risk factors for atrial fibrillation in older adults : the cardiovascular health study, J Am Geriatr Soc, vol.61, issue.2, pp.276-80, 2013. ,
Estimation of total incremental health care costs in patients with atrial fibrillation in the United States, Circulation, vol.4, issue.3, pp.313-333, 2011. ,
Cost of care distribution in atrial fibrillation patients: the COCAF study, American Heart Journal, vol.147, issue.1, pp.121-127, 2004. ,
, Société Française de Médecine d'Urgence. Prise en charge de la fibrillation auriculaire en médecine d'urgence Recommandations formalisées d'experts, 2015.
Les anticoagulants oraux directs ou AOD. Actualités pharmaceutiques, vol.53, pp.1-10, 2014. ,
, Agence nationale de sécurité du médicament et des produits de santé. Questions / Réponses pour les professionnels de santé. Quoi de neuf concernant les antivitamines K?, 2018.
Apixaban versus Warfarin in patients with atrial fibrillation, N Engl J Med, vol.365, issue.11, pp.981-92, 2011. ,
Dabigatran versus Warfarin in patients with atrial fibrillation, N Engl J Med, vol.361, issue.12, pp.1139-51, 2009. ,
Risk of bleeding with 2 doses of Dabigatran compared with Warfarin in older and younger patients with atrial fibrillation An analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial, Circulation, vol.123, issue.21, pp.2363-72, 2011. ,
Commission de la transparence -dabigatran étexilate, 2016. ,
Rivaroxaban versus Warfarin in nonvalvular atrial fibrillation, N Engl J Med, vol.365, issue.10, pp.883-91, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-01038111
Edoxaban versus Warfarin in patients with atrial fibrillation, N Engl J Med, vol.369, issue.22, pp.2093-104, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00934699
Idarucizumab : the antidote for reversal of dabigatran, vol.132, pp.2412-2434, 2015. ,
Andexanet Alfa for acute major bleeding associated with factor Xa Inhibitors, vol.375, pp.1131-1172, 2016. ,
Au moment d'être admis(e) à exercer la médecine, je promets et je jure d'être fidèle aux lois de l'honneur et de la probité ,
, Mon premier souci sera de rétablir, de préserver ou de promouvoir la santé dans tous ses éléments, physiques et mentaux, individuels et sociaux
, Je respecterai toutes les personnes, leur autonomie et leur volonté, sans aucune discrimination selon leur état ou leurs convictions
, J'interviendrai pour les protéger si elles sont affaiblies, vulnérables ou menacées dans leur intégrité ou leur dignité. Même sous la contrainte
, Je ne tromperai jamais leur confiance et n'exploiterai pas le pouvoir hérité des circonstances pour forcer les consciences
, Je ne me laisserai pas influencer par la soif du gain ou la recherche de la gloire
, Reçu(e) à l'intérieur des maisons, je respecterai les secrets des foyers et ma conduite ne servira pas à corrompre les moeurs
, Je ne prolongerai pas abusivement les agonies. Je ne provoquerai jamais la mort délibérément
, Je n'entreprendrai rien qui dépasse mes compétences. Je les entretiendrai et les perfectionnerai pour assurer au mieux les services qui me seront demandés
, J'apporterai mon aide à mes confrères ainsi qu'à leurs familles dans l'adversité
, Que les hommes et mes confrères m'accordent leur estime si je suis fidèle à mes promesses ; que je sois déshonoré(e) et méprisé(e) si j'y manque